Giuseppe Curigliano
Giuseppe Curigliano is a prominent oncologist and the elected president of the European Society of Medical Oncology (ESMO). He serves as the Director of the New Drug Development Division at the European Institute of Oncology in Milan. Curigliano is well-respected in the field for his work in cancer research and his advocacy for streamlining clinical trial approvals in Italy, aiming to enhance the country's competitiveness in global oncology research.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Italy | 1 | 9.00 | 0.07% | +0% | 60,461,826 | 44,920 | $2,000,000 | 1,486$ |
| Totals | 1 | 60,461,826 | 44,920 | $2,000,000 | 1,486$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Italy:
Giuseppe Curigliano is the director of the Division of New Drug Development at the European Institute of Oncology.
9
Italy:
Giuseppe Curigliano is the director of the Division of new drugs for innovative therapies at the European Institute of Oncology in Milan.
8
Italy:
Giuseppe Curigliano is an oncologist who has treated metastatic patients and is currently the Director of the Division of New Drug Development at the European Institute of Oncology in Milan.
9
Italy:
Giuseppe Curigliano is the elected president of the European Society of Medical Oncology and emphasizes the importance of reducing bureaucratic obstacles in cancer research.
7